Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Abbott announces definitive agreement to acquire Facet Biotech

Abbott announces definitive agreement to acquire Facet Biotech

Novel protein haditoxin in King Cobra's venom discovered

Novel protein haditoxin in King Cobra's venom discovered

Researchers examine benefits of collaboration between family physicians and community pharmacists

Researchers examine benefits of collaboration between family physicians and community pharmacists

State Roundup: N.Y. drug pricing, Vermont hospital ads, Massachusetts nursing homes and anti-psychotics

State Roundup: N.Y. drug pricing, Vermont hospital ads, Massachusetts nursing homes and anti-psychotics

RDS launches international outreach program on cognitive impairment in Down syndrome patients

RDS launches international outreach program on cognitive impairment in Down syndrome patients

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Likvor receives first order for Likvor CELDA system from Aalborg Hospital, North Denmark Region

Alzheimer's prevention initiative: Shared risks and shared rewards

Alzheimer's prevention initiative: Shared risks and shared rewards

Alzheimer’s healthcare crisis: EHE International donates display window at Rockefeller Center to help raise awareness

Alzheimer’s healthcare crisis: EHE International donates display window at Rockefeller Center to help raise awareness

New technologies have potential to help elderly people live independently

New technologies have potential to help elderly people live independently

Adults with depression and diabetes face increase risk of dementia

Adults with depression and diabetes face increase risk of dementia

RWJF awards $480,000 grant to improve clinical care for low-weight babies

RWJF awards $480,000 grant to improve clinical care for low-weight babies

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

Bristol-Myers Squibb to review key accomplishments at meeting with investment community

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

2010 Federal Budget lacks substantive funding in support of heart health initiatives: HSF concerned

Isotechnika Pharma receives grant of $237,069 to support NICAM program

Isotechnika Pharma receives grant of $237,069 to support NICAM program

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Beneficial Alzheimer's therapies, update on prevention efforts focused at ADI International Conference

Parkinson's patients find facial and vocal expression difficult to read; deep brain stimulation seems to make it worse

Parkinson's patients find facial and vocal expression difficult to read; deep brain stimulation seems to make it worse

25th Alzheimer's Disease International conference: Focus on new treatment developments

25th Alzheimer's Disease International conference: Focus on new treatment developments

Brain study may lead to new forms of treatment for Alzheimer's disease

Brain study may lead to new forms of treatment for Alzheimer's disease

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

Embedded wireless sensors in senior's homes to detect onset of dementia or physical infirmities

Failure of Alzheimer's drug Dimebon: Anavex Life Sciences comments

Failure of Alzheimer's drug Dimebon: Anavex Life Sciences comments

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.